Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COX-2 inhibition with celecoxib for chronic subdural hematoma recurrence
2008-000247-34Phase 3Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of celecoxib in Chronic subdural haematoma (CSDH) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Relapse rate of chronic subdural hematoma. Started Aug 2008; status: terminated.
02
Drugs
celecoxib
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on 2008-000247-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000247-34.